Breaking News Instant updates and real-time market news.

MESO

Mesoblast

$5.12

0.139 (2.79%)

, MNK

Mallinckrodt

$52.03

-0.4 (-0.76%)

17:27
12/22/16
12/22
17:27
12/22/16
17:27

Mesoblast and Mallinckrodt enter into equity purchase agreement

Mesoblast (MESO) has entered into an equity purchase agreement with Mallinckrodt (MNK) and will exclusively negotiate a commercial and development partnership for two of Mesoblast's Tier 1 product candidates, MPC-06-ID in the treatment or prevention of moderate/severe chronic low back pain due to disc degeneration and MSC-100-IV in the treatment of acute graft versus host disease. Under the terms of the agreement, Mallinckrodt will have an exclusive period of up to nine months to conclude commercial and development agreements for the two product candidates in all territories outside of Japan and China. As consideration, Mallinckrodt will purchase approximately 20.04 million, or 4.99%, of Mesoblast's ordinary shares at a price of A$1.4761 per share.

MESO

Mesoblast

$5.12

0.139 (2.79%)

MNK

Mallinckrodt

$52.03

-0.4 (-0.76%)

  • 09

    Jan

MESO Mesoblast
$5.12

0.139 (2.79%)

02/19/16
CHDN
02/19/16
INITIATION
Target $5.5
CHDN
Neutral
Mesoblast initiated with a Neutral at Chardan
Target $5.50.
03/07/16
JPMS
03/07/16
DOWNGRADE
Target $10
JPMS
Neutral
Mesoblast downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anupam Rama downgraded Mesoblast to Neutral citing the 44% year-to-date rise in the shares. The analyst has a $10 price target for the name.
06/14/16
FBCO
06/14/16
DOWNGRADE
Target $5
FBCO
Neutral
Mesoblast downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Alethia Young downgraded Mesoblast (MESO) to Neutral citing caution following the company's break-up with Teva (TEVA). Mesoblast should be able to find a new partner for its chronic heart failure program, but it could take some time, Young tells investors in a research note. She lowered her probability of success for the program to 25% from 40%. The analyst halved her price target for Mesoblast shares to $5 from $10. The shares have been halted since May 31, when they closed at $7.07.
06/15/16
JPMS
06/15/16
NO CHANGE
JPMS
Neutral
JPMorgan still cautious on Mesoblast, removes price target
JPMorgan analyst Anupam Rama says he remains cautious on Mesoblast (MESO) shares post the company's update related to MPC-150-IM in chronic heart failure. There are still some open questions following the two week trading halt, including why Teva (TEVA) has backed out following an interim data monitoring committee assessment and after committing resources to the program. The analyst sees growing concerns related to management credibility and removed his $10 price target for the stock. He keeps a Neutral rating on Mesoblast.
MNK Mallinckrodt
$52.03

-0.4 (-0.76%)

11/21/16
UBSW
11/21/16
NO CHANGE
Target $92
UBSW
Buy
Mallinckrodt weakness does not make sense, says UBS
UBS analyst Marc Goodman attended Mallinckrodt investors meetings and came away believing investors misunderstand the company story. The analyst said the company's Acthar drug, which has come under fire, has little relevance to the overall story. Goodman said the company has focused on enhancing clinical and health-economics data to help support better coverage and it is working. He said its emerging pipeline is under-appreciated. Goodman reiterated his Buy rating and $92 price target on Mallinckrodt shares.
11/30/16
LEER
11/30/16
NO CHANGE
Target $70
LEER
Outperform
Mallinckrodt price target lowered to $70 from $92 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Mallinckrodt to $70 from $92 following quarterly results due to a lack of near-term catalysts. The analyst reiterates an Outperform rating on the shares.
12/07/16
OPCO
12/07/16
INITIATION
Target $72
OPCO
Outperform
Mallinckrodt assumed with an Outperform at Oppenheimer
Oppenheimer analyst Derek Archila assumed coverage of Mallinckrodt with an Outperform rating but lowered his price target for the shares to $72 from $115. He views Acthar as a "durable growth asset" and believes Mallinckrodt remains well positioned to drive mid-to-high single-digit top line growth from the company's specialty brand segment.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

TSEM

Tower Semiconductor

$27.12

0.7 (2.65%)

13:30
08/23/17
08/23
13:30
08/23/17
13:30
Options
Bullish flow in Tower Semi as shares set 52-week highs »

Bullish flow in Tower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

13:30
08/23/17
08/23
13:30
08/23/17
13:30
General news
NY Fed accepted $169.8 B in daily reverse repos »

NY Fed accepted $169.8 B…

OMER

Omeros

$21.29

0.49 (2.36%)

13:22
08/23/17
08/23
13:22
08/23/17
13:22
Periodicals
Omeros 'still won't answer basic questions,' STAT's Feuerstein says »

Omeros' press…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUB

People's Utah Bancorp

$27.00

0.05 (0.19%)

13:20
08/23/17
08/23
13:20
08/23/17
13:20
Hot Stocks
People's Utah Bancorp CEO sells 12,170 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$20.44

0.54 (2.71%)

13:20
08/23/17
08/23
13:20
08/23/17
13:20
Options
Second day of interest in CenturyLink September puts »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

13:17
08/23/17
08/23
13:17
08/23/17
13:17
Hot Stocks
PetMed Express tells Bloomberg Aurelius report 'false and defamatory' »

In response to an earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

$NSD

NASDAQ Market Internals

13:17
08/23/17
08/23
13:17
08/23/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$118.03

-0.25 (-0.21%)

13:16
08/23/17
08/23
13:16
08/23/17
13:16
Conference/Events
Sempra Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 14

    Sep

$NYE

NYSE Market Internals

13:16
08/23/17
08/23
13:16
08/23/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
08/23/17
08/23
13:15
08/23/17
13:15
General news
Jackson Hole outlook: »

Jackson Hole outlook: the…

CAVM

Cavium

$60.98

0.84 (1.40%)

13:15
08/23/17
08/23
13:15
08/23/17
13:15
Conference/Events
Cavium has a conference call hosted by William Blair »

William Blair Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 06

    Sep

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

13:12
08/23/17
08/23
13:12
08/23/17
13:12
Recommendations
PetMed Express analyst commentary  »

PetMed Express recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

SIX

Six Flags

$51.97

-1.25 (-2.35%)

, DIS

Disney

$102.04

-0.73 (-0.71%)

13:06
08/23/17
08/23
13:06
08/23/17
13:06
Hot Stocks
Six Flags Magic Mountain to launch 365-day operation on January 1 »

Six Flags Entertainment…

SIX

Six Flags

$51.97

-1.25 (-2.35%)

DIS

Disney

$102.04

-0.73 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

S

Sprint

$8.29

0.065 (0.79%)

, SSNLF

Samsung

$2,030.00

-70 (-3.33%)

13:05
08/23/17
08/23
13:05
08/23/17
13:05
Hot Stocks
Samsung Galaxy Note8 coming to Sprint for $20 a month »

Sprint (S) announced the…

S

Sprint

$8.29

0.065 (0.79%)

SSNLF

Samsung

$2,030.00

-70 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

WSM

Williams-Sonoma

$43.04

0.19 (0.44%)

13:05
08/23/17
08/23
13:05
08/23/17
13:05
Options
Williams Sonoma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

MSI

Motorola Solutions

$86.67

0.26 (0.30%)

, ZURVY

Zurich Insurance

$30.34

-0.04 (-0.13%)

13:04
08/23/17
08/23
13:04
08/23/17
13:04
Hot Stocks
Motorola Solutions names Troy Mattern as head of product cybersecurity »

Motorola Solutions (MSI)…

MSI

Motorola Solutions

$86.67

0.26 (0.30%)

ZURVY

Zurich Insurance

$30.34

-0.04 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

HPQ

HP Inc.

$18.91

-0.115 (-0.60%)

, HPE

HP Enterprise

$17.69

0.02 (0.11%)

12:56
08/23/17
08/23
12:56
08/23/17
12:56
Earnings
On The Fly: What to watch in HP Inc.'s earnings report »

HP Inc. (HPQ) is…

HPQ

HP Inc.

$18.91

-0.115 (-0.60%)

HPE

HP Enterprise

$17.69

0.02 (0.11%)

LNVGY

Lenovo

$11.13

-0.07 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 29

    Aug

  • 31

    Aug

  • 01

    Sep

  • 05

    Sep

  • 06

    Sep

BABA

Alibaba

$173.90

-0.562 (-0.32%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on Alibaba »

Alibaba mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$16.04

0.29 (1.84%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on ON Semiconductor »

ON Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

KRO

Kronos Worldwide

$19.25

-0.25 (-1.28%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on Kronos Worldwide »

Kronos Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
08/23/17
08/23
12:55
08/23/17
12:55
General news
U.S. VIX equity volatility is up 4% near 11.82 »

U.S. VIX equity…

HCCI

Heritage-Crystal Clean

$18.15

-0.05 (-0.27%)

12:54
08/23/17
08/23
12:54
08/23/17
12:54
Periodicals
Breaking Periodicals news story on Heritage-Crystal Clean »

Heritage-Crystal Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 08

    Sep

  • 09

    Sep

12:50
08/23/17
08/23
12:50
08/23/17
12:50
General news
Breaking General news story  »

Dallas Federal Reserve…

CVM

CEL-SCI

$1.95

-0.341 (-14.89%)

12:47
08/23/17
08/23
12:47
08/23/17
12:47
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI »

Sabby Management reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

12:46
08/23/17
08/23
12:46
08/23/17
12:46
Periodicals
PetMed Express 'exploiting' opioid epidemic in America, Aurelius Value says »

PetMed Express is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.